Ethic Inc. Has $5.58 Million Stock Holdings in Xylem Inc. $XYL

Ethic Inc. raised its stake in shares of Xylem Inc. (NYSE:XYL) by 3.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 43,500 shares of the industrial products company’s stock after purchasing an additional 1,567 shares during the quarter. Ethic Inc.’s holdings in Xylem were worth $5,578,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its holdings in shares of Xylem by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 29,006,544 shares of the industrial products company’s stock worth $3,465,122,000 after acquiring an additional 362,127 shares in the last quarter. Swedbank AB raised its position in Xylem by 13.9% in the 2nd quarter. Swedbank AB now owns 4,366,932 shares of the industrial products company’s stock worth $564,906,000 after purchasing an additional 531,890 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Xylem by 7.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,024,500 shares of the industrial products company’s stock worth $480,767,000 after purchasing an additional 274,123 shares during the last quarter. Price T Rowe Associates Inc. MD raised its position in Xylem by 689.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company’s stock worth $443,074,000 after purchasing an additional 3,239,203 shares during the last quarter. Finally, Northern Trust Corp raised its position in Xylem by 2.9% in the 1st quarter. Northern Trust Corp now owns 3,362,993 shares of the industrial products company’s stock worth $401,743,000 after purchasing an additional 94,560 shares during the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on XYL. Cowen restated a “hold” rating on shares of Xylem in a research report on Tuesday, August 26th. Barclays began coverage on shares of Xylem in a research report on Friday, September 19th. They issued an “overweight” rating and a $165.00 price objective for the company. Weiss Ratings restated a “buy (b)” rating on shares of Xylem in a research report on Wednesday, October 8th. Zacks Research upgraded shares of Xylem from a “hold” rating to a “strong-buy” rating in a research report on Monday, September 22nd. Finally, Mizuho boosted their price objective on shares of Xylem from $125.00 to $140.00 and gave the stock a “neutral” rating in a research report on Friday, September 12th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, Xylem currently has an average rating of “Moderate Buy” and an average price target of $154.67.

Xylem Price Performance

Shares of XYL stock opened at $146.03 on Thursday. Xylem Inc. has a 12-month low of $100.47 and a 12-month high of $151.16. The firm has a market capitalization of $35.54 billion, a price-to-earnings ratio of 37.93, a price-to-earnings-growth ratio of 2.51 and a beta of 1.13. The company has a quick ratio of 1.43, a current ratio of 1.90 and a debt-to-equity ratio of 0.17. The firm has a fifty day moving average of $143.52 and a 200-day moving average of $131.94.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.15 by $0.11. The company had revenue of $2.30 billion during the quarter, compared to analyst estimates of $2.20 billion. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The firm’s revenue was up 6.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.09 EPS. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. On average, equities research analysts forecast that Xylem Inc. will post 4.65 earnings per share for the current year.

Xylem Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Thursday, August 28th were paid a $0.40 dividend. The ex-dividend date of this dividend was Thursday, August 28th. This represents a $1.60 dividend on an annualized basis and a yield of 1.1%. Xylem’s dividend payout ratio is presently 41.56%.

Insiders Place Their Bets

In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company’s stock in a transaction on Friday, September 5th. The shares were sold at an average price of $139.96, for a total value of $139,960.00. Following the completion of the transaction, the chief accounting officer directly owned 2,957 shares of the company’s stock, valued at approximately $413,861.72. This represents a 25.27% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.27% of the company’s stock.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.